Next Article in Journal
Antioxidant, Anti-Tyrosinase and Anti-Inflammatory Activities of Oil Production Residues from Camellia tenuifloria
Next Article in Special Issue
Microtubule-Associated Protein SBgLR Facilitates Storage Protein Deposition and Its Expression Leads to Lysine Content Increase in Transgenic Maize Endosperm
Previous Article in Journal
Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
Previous Article in Special Issue
Maize-Pathogen Interactions: An Ongoing Combat from a Proteomics Perspective
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(12), 29508-29521;

Proteomic Investigations into Hemodialysis Therapy

Nephrology and Dialysis Institute, Department of Medicine, G. d’Annunzio University, Chieti-Pescara, SS. Annunziata Hospital, Via dei Vestini, 66013 Chieti, Italy
Proteomics and Metabonomics Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) S. Lucia Foundation, 00179 Rome, Italy
Department of Surgery and Experimental Medicine, Tor Vergata University, 00134 Rome, Italy
Author to whom correspondence should be addressed.
Academic Editor: Ali Mobasheri
Received: 30 October 2015 / Revised: 26 November 2015 / Accepted: 2 December 2015 / Published: 10 December 2015
(This article belongs to the Collection Advances in Proteomic Research)
Full-Text   |   PDF [392 KB, uploaded 10 December 2015]   |  


The retention of a number of solutes that may cause adverse biochemical/biological effects, called uremic toxins, characterizes uremic syndrome. Uremia therapy is based on renal replacement therapy, hemodialysis being the most commonly used modality. The membrane contained in the hemodialyzer represents the ultimate determinant of the success and quality of hemodialysis therapy. Membrane’s performance can be evaluated in terms of removal efficiency for unwanted solutes and excess fluid, and minimization of negative interactions between the membrane material and blood components that define the membrane’s bio(in)compatibility. Given the high concentration of plasma proteins and the complexity of structural functional relationships of this class of molecules, the performance of a membrane is highly influenced by its interaction with the plasma protein repertoire. Proteomic investigations have been increasingly applied to describe the protein uremic milieu, to compare the blood purification efficiency of different dialyzer membranes or different extracorporeal techniques, and to evaluate the adsorption of plasma proteins onto hemodialysis membranes. In this article, we aim to highlight investigations in the hemodialysis setting making use of recent developments in proteomic technologies. Examples are presented of why proteomics may be helpful to nephrology and may possibly affect future directions in renal research. View Full-Text
Keywords: proteomic; hemodialysis; uremic toxins; biocompatibility; dialysis membrane proteomic; hemodialysis; uremic toxins; biocompatibility; dialysis membrane

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Bonomini, M.; Sirolli, V.; Pieroni, L.; Felaco, P.; Amoroso, L.; Urbani, A. Proteomic Investigations into Hemodialysis Therapy. Int. J. Mol. Sci. 2015, 16, 29508-29521.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top